Skip to main content

Leukemia

Leukemia, Oncology
Novel Anti-CD20 Antibodies Show Promising Results in Unfit Patients with Chronic Lymphocytic Leukemia
Wayne Kuznar
Read More
Leukemia, Oncology
Promising Drugs in the Pipeline for Leukemia and Myelodysplastic Syndromes
Wayne Kuznar
Read More
Leukemia, Oncology
Initial Choice of TKI in Patients with CML Probably Not Important
Mark Knight
Read More
Leukemia, Oncology
Evidence Lacking for Eliminating Prophylactic Platelet Transfusions
Audrey Andrews
Read More
Leukemia, Oncology
Ibrutinib: It’s Not Just for Leukemia
Audrey Andrews
Read More
Leukemia, Oncology
Molecular and Cytogenetic Assessments Infrequently Performed in Patients with CML Receiving First-Line Imatinib
Mark Knight
Read More
Leukemia, Oncology
Alternatives to “7 + 3” Induction Therapy for AML Are Emerging
Wayne Kuznar
Read More
Leukemia, Oncology
Fast Response Identifies Patients with CML for Entry into Studies of Imatinib Discontinuation
Wayne Kuznar
Read More
Leukemia, Oncology
“Dramatic” Responses with Targeted Agent for Patients with CLL
Charles Bankhead
Read More
Leukemia, Oncology
New Oral TKI Ponatinib Produces High Response Rates in Hard-to-Treat Leukemia
Wayne Kuznar
Read More
Page 6 of 7
Results 51 - 60 of 70